Name: Latest research reports of Zydus Lifesciences Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Zydus Lifesciences Ltd.
Rating: 5
Author: Motilal Oswal

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer

993.4500 -1.00 (-0.10%)

NSE Oct 10, 2025 15:31 PM

Volume: 1.6M

Zydus Lifesciences Ltd.

03 Aug 2016

993.45

-0.10%

Cadila Health: 1Q FY17 sales disappoint; margins continue to remain r

Buy: Zydus Lifesciences Ltd.

Motilal Oswal

1QFY17 sales disappoint; margins continue to remain robust Motilal Oswal values your support in the Asiamoney Brokers Poll 2016 for...

Zydus Lifesciences Ltd. is trading above its 200 day SMA of 949.7